Jeffrey Zhang

3.1k total citations · 1 hit paper
50 papers, 1.9k citations indexed

About

Jeffrey Zhang is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Jeffrey Zhang has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jeffrey Zhang's work include Amyotrophic Lateral Sclerosis Research (6 papers), Sleep and related disorders (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Jeffrey Zhang is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (6 papers), Sleep and related disorders (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Jeffrey Zhang collaborates with scholars based in United States, Canada and Japan. Jeffrey Zhang's co-authors include Sherry Wang‐Weigand, Thomas Roth, David Seiden, Stephen M. Sainati, Jay R. Lieberman, Roberto Iglesias, Marc H. Hedrick, Prosper Benhaim, Mandar A. Aras and Sanjiv J. Shah and has published in prestigious journals such as Nature, Circulation and Nature Communications.

In The Last Decade

Jeffrey Zhang

47 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fully Automated Echocardiogram Interpretation in Clinical Practice

2018 568 citations Jeffrey Zhang, Sravani Gajjala et al. Circulation profile →

Peers

Jeffrey Zhang

ECP

CCM

EAS

RNMI

Lyle J. Olson United States

Xian Liu China

Hua Ting Taiwan

Mi Ji Lee South Korea

Hiroshi Horibe Japan

Qi Fang China

Yusuke Uemura Japan

Chao Han China

Ryo Otsuka Japan

Yūji Takahashi Japan

Lyle J. Olson United States

Jeffrey Zhang

281 ×0.7

ECP

280 ×0.7

2.1k ×6.1

CCM

1.4k ×4.0

EAS

146 ×0.5

RNMI

Citations per year, relative to Jeffrey Zhang Jeffrey Zhang (= 1×) peers Lyle J. Olson

Countries citing papers authored by Jeffrey Zhang

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Zhang more than expected).

Fields of papers citing papers by Jeffrey Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Zhang. The network helps show where Jeffrey Zhang may publish in the future.

Co-authorship network of co-authors of Jeffrey Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Zhang. A scholar is included among the top collaborators of Jeffrey Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Zhang. Jeffrey Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hou, Ke, P. Ge, M.R. Sawaya, et al.. (2025). How short peptides disassemble tau fibrils in Alzheimer’s disease. Nature. 644(8078). 1020–1027. 3 indexed citations

Bajaj, Jasmohan S., Ethan M. Weinberg, K. Rajender Reddy, et al.. (2025). Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites. Liver Transplantation. 31(10). 1202–1214. 2 indexed citations

Zhang, Jeffrey, et al.. (2025). The effects of a smoking cessation intervention on mortality after a 32.5-year follow-up period: a randomized clinical trial. American Journal of Epidemiology.

Reading, Christopher L., Jiayan Yan, Marcia A. Testa, et al.. (2025). An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. Frontiers in Neuroscience. 19. 1516746–1516746. 1 indexed citations

Pioro, Erik P., et al.. (2024). Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial. Journal of the Neurological Sciences. 467. 123290–123290. 4 indexed citations

Kim, Sungsoon, Jeffrey Zhang, Fan Yang, et al.. (2024). Enhanced phosphate anion flux through single-ion, reverse-selective mixed-matrix cation exchange membrane. SHILAP Revista de lepidopterología. 4(2). 100086–100086. 1 indexed citations

Goyal, Manu S., Jeffrey Zhang, Dylan S. Small, et al.. (2024). MRI-Based Brain Volume Scoring in Cerebral Malaria Is Externally Valid and Applicable to Lower-Resolution Images. American Journal of Neuroradiology. 45(2). 205–210. 1 indexed citations

Brooks, Benjamin Rix, et al.. (2022). Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis. EClinicalMedicine. 52. 101590–101590. 32 indexed citations

Bruen, Charles, Edward A. Michelson, Maged Tanios, et al.. (2022). Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial. Critical Care. 26(1). 101–101. 25 indexed citations

10.

Brooks, Benjamin Rix, et al.. (2022). Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]. PLoS ONE. 17(6). e0258614–e0258614. 17 indexed citations

11.

Alphonse, Martin P., Roger V. Ortines, Aman M. Patel, et al.. (2021). Pan-caspase inhibition as a potential host-directed immunotherapy against MRSA and other bacterial skin infections. Science Translational Medicine. 13(601). 33 indexed citations

12.

Miller, Joseph M., Charles Bruen, Jeffrey Zhang, et al.. (2020). Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial. Critical Care. 24(1). 502–502. 55 indexed citations

13.

Ottery, Faith D., et al.. (2019). PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers. BioDrugs. 33(2). 207–220. 10 indexed citations

14.

Zhang, Jeffrey, Sravani Gajjala, Pulkit Agrawal, et al.. (2018). Fully Automated Echocardiogram Interpretation in Clinical Practice. Circulation. 138(16). 1623–1635. 568 indexed citations breakdown →

15.

Schiødt, Morten, Saroj Vadhan‐Raj, Mark S. Chambers, et al.. (2017). A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Supportive Care in Cancer. 26(6). 1905–1915. 44 indexed citations

16.

Stalker, Dennis J., et al.. (2016). Pharmacodynamic and Pharmacokinetic Equivalences of Epoetin Hospira and Epogen® After Multiple Subcutaneous Doses to Healthy Male Subjects. Clinical Therapeutics. 38(5). 1090–1101. 6 indexed citations

17.

Richardson, Gary S., Gary Zammit, Sherry Wang‐Weigand, & Jeffrey Zhang. (2009). Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia. The Journal of Clinical Psychiatry. 70(4). 467–476. 40 indexed citations

18.

Kryger, Meir H., Thomas Roth, Sherry Wang‐Weigand, & Jeffrey Zhang. (2008). The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. Sleep And Breathing. 13(1). 79–84. 43 indexed citations

19.

Kryger, Meir H., Sherry Wang‐Weigand, Jeffrey Zhang, & Thomas Roth. (2007). Effect of Ramelteon, a selective MT1/MT2-receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep And Breathing. 12(3). 243–250. 22 indexed citations

20.

Iglesias, Roberto, et al.. (2005). Genetically Modified Human Derived Bone Marrow Cells for Posterolateral Lumbar Spine Fusion in Athymic Rats. Spine. 30(3). 283–289. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact